{"disease":{"id":"hemophagocytic-lymphohistiocytoses","name":"hemophagocytic lymphohistiocytoses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03546101","title":"Early Detection of Epstein-Barr Virus Related Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":1527,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05491304","title":"Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05882175","title":"Prospective Validation of the OHI Index","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT06585124","title":"Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03117010","title":"Prospective Cohort for Adult Hemophagocytosis","phase":"","overall_status":"RECRUITING","enrollment_count":81,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05600959","title":"Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05531721","title":"HLH Patients - a Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna","has_results":false},{"nct_id":"NCT06160791","title":"Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Jerry Lee, MD, MSc, MPhil","has_results":false},{"nct_id":"NCT05677178","title":"Response Prediction in EBV-HLH Using Metabonomics Analysis","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05988177","title":"Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06504030","title":"Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07034209","title":"A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"TJ Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT06491719","title":"A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06047210","title":"Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT03985423","title":"A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT05236764","title":"Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Baylor College of Medicine","has_results":true}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}